Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
532321
Company
Zydus Lifesciences Ltd
Exchange Received Time
25/05/2018 15:23:45
Exchange Disseminated Time
25/05/2018 15:23:52
Time Taken
00:00:07
Board Meeting-Outcome of Board Meeting |
5/25/2018 3:23:45 PM
We hereby inform that the Board of Directors at their meeting held today considered and approved in-principle, the following fund raising proposals, which are subject to approval of the members at the ensuing Annual General Meeting:
(i) to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, for an aggregate amount up to Rs. 10,000 crores,
(ii) to issue Secured / Unsecured Redeemable Non-Convertible Debentures / Foreign Currency Bonds on Private Placement Basis for an amount up to Rs. 3,500 crores in the Financial Year 2017-2018 and
(iii) to issue Foreign Currency Bond / Foreign Currency Convertible Bonds for an amount up to Rs. 5,000 crores.
Attachment
<< Back
Recently Viewed